Each year, a new traumatic brain injury (TBI) event occurs in an estimated 10 million people worldwide, particularly in young adults. Not only is TBI the leading cause of longterm disability and mortality worldwide, but it is also expected to become the third largest cause of global disease burden by 2020 [1, 2] . TBI is a challenging disease process, both to treat and to investigate. TBI survivors often experience substantial and lifelong cognitive, physical, and behavioral impairments that require long-term access to health care and disability services.
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Over the past three decades, imaging modalities, such as positron emission tomography (PET), functional MRI (fMRI), diffusion tensor imaging (DTI), and transcranial magnetic stimulation (TMS), have played a pivotal role in predicting TBI outcome and advancing TBI treatment [3] .
Burgeoning evidences for neuroplasticity have shed light on the potential therapeutic protocols focusing on synaptic proteins, new network connections, inflammatory reactions, and the recruitment of immune cells [4] . Future therapies, including gene therapies or a combination of different pharmacologic therapies and rehabilitative protocols, which may benefit victims by targeting multiple mechanisms of recovery, are of utmost interest and currently under heavy investigation by devoting neuroscientists.
The articles contained in this special issue include 4 reviews and 2 original research papers: a quantitative study focusing on predictors of recovery from TBI and a cohort study on substance related disorder after TBI.
(i) TBI survivors suffer various functional and cognitive sequelae that may impose serious medical and social problems. J. Ma et al. reviewed the complicated pathological mechanisms of diffuse axonal injury (DAI) in an attempt to facilitate more accurate diagnosis and hence improve the survival and life quality of DAI patients.
(ii) Not many studies have discussed the role of synapses after TBI. Z. Wen et al. provided a comprehensive review on the role and mechanisms of synapses in TBI and the correlation between key synaptic proteins and neuroplasticity. The article also provides insights on the role of synapses in the treatment and prognosis of TBI.
(iii) Molecular studies concerning the microglia-induced inflammation by M1 phenotype and antiinflammation by M2 phenotype are a new strategy for treatment of TBI. In the paper titled "The Taiwan. " Results show that the overall incidence of SRD was 3.62-fold higher in the TBI group and 9.01-fold in the severe TBI group. The severity of TBI seems to have strong correlation in the subsequent risks of SRD.
